SCI SPARC

SciSparc is managed by an established team with a proven track record of execution in drug development, working in concert with a world class, award-winning, scientific advisory board chaired by the renowned Professor Raphael Mechoulam. Together they bring decades of experience in biochemistry and pharmacology, research and development, manufacturing, international distribution, clinical and regulatory affairs, as well as financial acumen to the SciSparc operation... SciSparc's proprietary compounds capitalize on the biochemistry of receptors that specialize in modulating the central nervous system to create therapeutics that mitigate the adverse symptoms associated with CNS disorders... Enhancing existing compounds with our proprietary technologies, we have developed novel therapies that demonstrate in clinical trials heightened bioavailability, significantly improved efficacy, lower dosage requirements, better safety profiles and a reduction in side effects.

Also known as: SciSparc Ltd.

Primary location: Tel-aviv Israel